BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9122278)

  • 1. Long-circulating lipospheres targeted to the inflammed tissue.
    Khopade AJ; Jain NK
    Pharmazie; 1997 Feb; 52(2):165-6. PubMed ID: 9122278
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A; Jantrawut P; Manosroi J
    Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
    Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
    Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule based proliposomes.
    Katare OP; Vyas SP; Dixit VK
    J Microencapsul; 1995; 12(5):487-93. PubMed ID: 8544092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting to inflammation: studies on antioxidant surface loaded diclofenac liposomes.
    Jukanti R; Devaraj G; Devaraj R; Apte S
    Int J Pharm; 2011 Jul; 414(1-2):179-85. PubMed ID: 21605645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
    Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of an antiphlogistic incorporated in liposomes on experimentally induced inflammation.
    Schramlová J; Blazek K; Otová B; Bartácková M; Hulínská D
    Folia Biol (Praha); 1997; 43(5):195-9. PubMed ID: 9595260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
    Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
    Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Diclofenac-carrier for local treatment of osteoarthritis applying live-animal MRI.
    Elron-Gross I; Glucksam Y; Biton IE; Margalit R
    J Control Release; 2009 Apr; 135(1):65-70. PubMed ID: 19146892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of diclofenac-induced anti-inflammatory response by aminoguanidine in carrageenan-induced acute inflammation in rats: the role of nitric oxide.
    Al-Majed AA; Khattab M; Raza M; Al-Shabanah OA; Mostafa AM
    Inflamm Res; 2003 Sep; 52(9):378-82. PubMed ID: 14504665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
    El Zaafarany GM; Awad GA; Holayel SM; Mortada ND
    Int J Pharm; 2010 Sep; 397(1-2):164-72. PubMed ID: 20599487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies.
    Saravanan M; Bhaskar K; Narayanan NV; Maharajan G; Pillai KS
    Boll Chim Farm; 2003 Oct; 142(8):347-51. PubMed ID: 15040465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
    Mutalik S; Anju P; Manoj K; Usha AN
    Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
    Li N; Zhuang C; Wang M; Sun X; Nie S; Pan W
    Int J Pharm; 2009 Sep; 379(1):131-8. PubMed ID: 19559775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery.
    Vyas SP; Singh R; Asati RK
    J Microencapsul; 1995; 12(2):149-54. PubMed ID: 7629657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutical and pharmacodynamic studies on topically applied diclofenac gel available in Indian market.
    Bhaskar K; Ramachandran S; Sridhar SK; Rajarajan AT; Ramkumar A; Sanathkumar K; Srinivasa Rao G; Anbu J; Dhanaraju MD; Saravanan M
    Boll Chim Farm; 2004 Jun; 143(5):208-10. PubMed ID: 15360107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable poly(alpha-methylmalate) microspheres.
    Yoncheva K; Lambov N
    Pharmazie; 2000 Feb; 55(2):148-50. PubMed ID: 10723779
    [No Abstract]   [Full Text] [Related]  

  • 20. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes.
    Fujisawa T; Miyai H; Hironaka K; Tsukamoto T; Tahara K; Tozuka Y; Ito M; Takeuchi H
    Int J Pharm; 2012 Oct; 436(1-2):564-7. PubMed ID: 22828072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.